Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT

Bone Marrow Transplant. 2024 Dec 3. doi: 10.1038/s41409-024-02487-w. Online ahead of print.
No abstract available

Publication types

  • Letter